Hormone Therapy & Mammography Working GroupPurpose: To assess the impact of use of Hormone Therapy (HT) on breast cancer screening performance across countries. Members: Brian Cox (chair), Rachel Ballard-Barbash, Mireille Broeders, Emily Dowling, Berta Geller, Nea Malila, Rene Shumak, Stephen Taplin Activities: The group will review the effect of HT on incidence, mortality, sensitivity and specificity of breast screening by mammography; will survey international screening programs about their recording of the use of HT; assess which programs have sufficient data for analysis of the effectiveness of mammography in HT users versus non-HT users; record how breast density is measured and recorded in these screening programs; and investigate the measurement of breast screening program performance in the presence of HT use. |
Last modified: 19 Oct 2007 Accessibility Feedback | Privacy Policy & Disclaimers |
Maintained by the
Applied Research Program,
Division of Cancer Control and Population Sciences. |